News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Mills C Randal
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/28/2023 |
4
| Mills C Randal (PRESIDENT AND CEO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns:
| Granted 134,840 restricted stock units
@ $0 Exercised 44,947 restricted stock units
@ $0 Granted 89,894 restricted stock units
@ $0 |
|
06/23/2022 |
4
| Mills C Randal (Interim President and CEO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns:
| Granted 273,767 options to buy
@ $6.39, valued at
$1.7M
Granted 182,511 options to buy
@ $6.39, valued at
$1.2M
|
|
06/09/2022 |
4
| Mills C Randal (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns:
| Granted 22,090 options to buy
@ $6.28, valued at
$138.7k
|
|
06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2020 |
4
| Mills C Randal (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns:
| Granted 14,307 options to buy
@ $17, valued at
$243.2k
|
|
10/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/06/2012 |
4/A
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns:
| Granted options to buy
@ $5.08, valued at
$0 |
|
06/07/2011 |
4
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns:
| Gifted 500 shares
@ $6.97, valued at
$3.5k
|
|
02/16/2011 |
4
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns:
| Granted 13,169 options to buy
@ $7.13, valued at
$93.9k
Granted 26,831 options to buy
@ $7.13, valued at
$191.3k
|
|
03/16/2010 |
4
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns:
| Granted 40,000 options to buy
@ $7.74, valued at
$309.6k
|
|
08/05/2009 |
4
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
02/25/2009 |
4
| Mills C Randal (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
02/14/2007 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
|
|